Edition:
United States

Retrophin Inc (RTRX.O)

RTRX.O on Consolidated Issue listed on NASDAQ Global Market

23.46USD
14 Nov 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$23.46
Open
$24.58
Day's High
$24.94
Day's Low
$23.27
Volume
339,349
Avg. Vol
349,983
52-wk High
$33.00
52-wk Low
$20.09

Chart for

About

Retrophin, Inc. is a biopharmaceutical company. The Company is focused on the development, acquisition and commercialization of therapies for the treatment of serious, catastrophic or rare diseases. The Company sells three products, including Chenodal (chenodeoxycholic acid), Cholbam (cholic acid) and Thiola (tiopronin). Its... (more)

Overall

Beta: 1.20
Market Cap(Mil.): $999.02
Shares Outstanding(Mil.): 41.25
Dividend: --
Yield (%): --

Financials

  RTRX.O Industry Sector
P/E (TTM): -- 80.78 29.53
EPS (TTM): -2.77 -- --
ROI: -21.24 -0.24 13.00
ROE: -35.87 -3.00 14.69

Earnings vs. Estimates